AVE 0.00% 0.2¢ avecho biotechnology limited

Ann: Oxymorphone Patch Program Update, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 642 Posts.
    lightbulb Created with Sketch. 9
    Unbelievable. For how long can we put up with this rubbish.
    They must have known after the trials that they needed to re formulate the patches. But no, at the last AGM it was all gung ho ahead.
    I am seriously starting to think that we have never been told the full story.
    Harry Rosen said at the last AGM "our technology is impeccable".
    Why do we need external consultants to fix this problem. POH has been researching patches for over a decade. I would have thought they should be the experts.
    I have stuck by this company and been loyal to its staff and technology since the Vital days, but this has really peed me off beyond belief.
    If Paul Gavin can explain why his peers have rejected his publications, I would be seriously surprised. People such as this should be held to account over their promises. He should fall on hi sword and I hope he cops a flogging at the AGM, if he has the nerve to turn up.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
0.000(0.00%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
24 35707771 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 40153304 27
View Market Depth
Last trade - 10.00am 11/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.